Article
CRACD suppresses neuroendocrinal plasticity of lung adenocarcinoma
2023-04-21
Abstract excerpt
Tumor cell plasticity contributes to intratumoral heterogeneity and therapy resistance. Through cell plasticity, lung adenocarcinoma (LUAD) cells transform into neuroendocrinal (NE) tumor cells. However, the mechanisms of NE cell plasticity remain unclear. CRACD, a capping protein inhibitor, is frequently inactivated in cancers. CRACD knock-out (KO) de-represses NE-related gene expression in the pulmonary epithel...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cb4b1335-6126-5d77-a568-ddca29d2a4b0
- DOI
- 10.1101/2023.04.19.537576
